COMMUNIQUÉS West-GlobeNewswire

-
Sales of Olainfarm Continue Growing in February
15/03/2019 -
BBS-Bioactive Bone Substitutes Plc: Correction to the invitation to annual general meeting of BBS-Bioactive Bone Substitutes Plc published on 15.03.2019 at 12:00 CET
15/03/2019 -
Diamond CBD to Showcase Exciting New Product Lines at ASD Market Week
15/03/2019 -
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
15/03/2019 -
Vilacto Bio Canada Patent LACTOACTIVE® Granted
15/03/2019 -
Outlook Therapeutics Announces Reverse Stock Split
15/03/2019 -
Helix TCS Expands into Global Markets -- CFN Media
15/03/2019 -
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
15/03/2019 -
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
15/03/2019 -
Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program
15/03/2019 -
Matrix Medical Network showcases state-of-the-art mobile health clinic at RISE Nashville
15/03/2019 -
Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
15/03/2019 -
Extendicare Announces March 2019 Dividend of C$0.04 per Share
15/03/2019 -
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results
15/03/2019 -
AzurRx BioPharma to Present at the 2019 Annual Roth Capital Conference (March 19) and the Oppenheimer 29th Annual Healthcare Conference (March 20)
15/03/2019 -
Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
15/03/2019 -
ProMIS Neurosciences Announces Fiscal Year 2018 Annual Results
15/03/2019 -
OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights
15/03/2019 -
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
15/03/2019
Pages